Palvella Therapeutics Cash Flow Statement (2013-2026) | PVLA

Cash Flow Statement Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-16.76M-19.01M-11.01M-7.46M-12.20M-11.93M-15.15M2.55M-11.26M13.39M-2.54M-4.17M-6.78M13.48M-8.19M-9.47M-11.35M29.07M-15.77M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
1.33M1.37M1.32M1.18M1.30M0.97M0.95M0.88M1.05M0.97M-2.29M0.15M0.22M0.20M0.27M1.09M1.43M1.79M2.08M3.38M
Gains from Investment Securities (Quarter)
-0.04M-0.21M0.51M-0.21M-0.07M0.18M0.02M-0.08M-0.02M0.33M0.89M2.70M0.05M2.92M0.00M
Asset Writedowns and Impairment (Quarter)
14.89M-0.98M
Non-cash Items (Quarter)
0.11M0.42M0.50M0.58M20.50M0.84M0.95M
Cash from Operations (Quarter)
29.91M-14.48M-10.94M-22.64M-15.58M-8.78M-12.93M-11.00M-13.43M-9.72M20.45M-1.10M-1.60M-2.74M-5.39M-6.77M-5.43M-7.88M-4.92M-10.90M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.02M0.01M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)
0.62M0.61M0.61M0.84M0.58M0.77M0.57M0.60M0.76M0.74M-0.20M-0.03M
Change in Working Capital
Change in Receivables (Quarter)
-0.36M-0.03M
Change in Account Payables (Quarter)
0.09M0.42M1.69M0.04M1.12M0.12M-1.14M1.16M0.85M
Change in Accured Expenses (Quarter)
0.29M0.74M0.38M-0.36M-2.91M0.52M0.80M0.29M-0.90M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
-43.46M-0.06M34.78M19.65M7.29M0.45M-26.40M-0.61M18.89M15.52M-34.08M-0.05M0.16M0.13M1.26M-0.96M-0.18M-0.22M0.36M
Investing Activities
Capital Expenditures (Quarter)
0.23M-0.26M0.95M0.30M-0.28M0.02M1.01M0.05M0.03M0.11M-0.18M
Sales of Property, Plant and Equipment (Quarter)
0.14M
Change in Acquisitions & Divestments (Quarter)
4.85M17.05M6.30M13.49M5.40M5.11M11.00M9.00M
Cash from Investing Activities (Quarter)
-0.23M-0.35M-0.34M-16.95M-10.87M5.47M1.11M11.90M-1.37M-1.98M3.45M9.00M2.18M0.14M-55.44M
Financing Activities
Other financing activities (Quarter)
14.25M
Cash from Financing Activities (Quarter)
22.62M21.92M4.90M6.56M0.28M0.28M0.09M19.78M-14.78M9.89M2.41M74.78M-1.20M0.35M0.24M-0.05M214.73M
Additional items
Exchange Rate Effect (Quarter)
-0.03M-1.13M-0.90M-0.99M-3.32M-2.81M1.95M0.20M0.21M-0.34M-0.07M0.00M-0.01M-0.11M0.77M-0.61M-0.01M
Change in Cash (Quarter)
52.26M5.96M-7.29M-34.03M-29.48M-5.83M-9.79M1.11M5.20M-12.04M-2.96M-1.10M8.29M-0.33M69.39M-7.98M-5.19M-6.87M-5.58M148.41M
Free Cash Flow (Quarter)
29.68M-14.23M-11.89M-22.94M-15.29M-8.79M-13.94M-11.04M-13.46M-9.83M20.63M-1.10M-1.60M-2.74M-5.39M-6.77M-5.43M-7.88M-4.92M-10.90M
Net Cash Flow (Quarter)
52.29M7.08M-6.38M-33.03M-26.16M-3.03M-11.73M0.91M4.98M-11.71M9.12M7.90M10.46M-0.19M69.39M-7.97M-5.08M-7.64M-4.97M148.39M